Showing results (81-90 of 174) with videos related to
Sort By:
Pageof 18
Virus Evolution|January 21, 2026
Intra-host GI.1 norovirus evolution is shaped by genetic drift and purifying selectionKentaro Tohma, Pengbo Liu, Katia Koelle, et al.Archives of Virology|March 10, 2010
Predominance of rotavirus G2P[4] and emergence of G12P[9] strains in Asunción, Paraguay, 2006-2007Magaly Martínez, Alberto A Amarilla, Maria E Galeano, et al.Vaccine|April 4, 2012
Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulationsGabriel I Parra, Karin Bok, Ross Taylor, et al.Journal of Virology|May 30, 2025
Highly variable antigenic site located at the apex of GII.4 norovirus capsid protein induces cross-reactive blocking antibodies in a variant-specific mannerMichael Landivar, Kentaro Tohma, Kelsey A Pilewski, et al.Allergologia Et Immunopathologia|March 1, 1993
Asthma and vasculitis. Response to intravenous immunoglobulinsA Armentia, A Fernández, P Sánchez, et al.Microbiological Research|July 23, 2021
Integrated omics approaches for deciphering antifungal metabolites produced by a novel Bacillus species, B. cabrialesii TE3<sup>T</sup>, against the spot blotch disease of wheat (Triticum turgidum L. subsp. durum)Eber Villa-Rodriguez, Aldo Moreno-Ulloa, Ernestina Castro-Longoria, et al.Journal of Crohn'S & Colitis|December 22, 2010
Pneumonia due to Nocardia cyriacigeorgica in a patient with Crohn's disease treated with infliximabM I Parra, M C Martinez, M A Remacha, et al.Viruses|March 3, 2019
Genomics Analyses of GIV and GVI Noroviruses Reveal the Distinct Clustering of Human and Animal VirusesLauren A Ford-Siltz, Lisa Mullis, Yasser M Sanad, et al.Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|November 21, 2016
Benefit in long-term response and mortality of treatment with intravenous immunoglobulin prior to plasmapheresis in peripheral polyneuropathiesI Parra-Salinas, V P González-Rodríguez, J A Gracia Pina, et al.Emerging Infectious Diseases|April 26, 2024
Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong 2019Kentaro Tohma, Michael Landivar, Lauren A Ford-Siltz, et al.Pageof 18